Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 01 June, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 538666 | NSE: SHARDACROP

Sharda Cropchem Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 31, 2025, 8:40 pm

Market Cap 6,657 Cr.
Current Price 738
High / Low 887/345
Stock P/E21.9
Book Value 277
Dividend Yield0.41 %
ROCE16.0 %
ROE12.8 %
Face Value 10.0
PEG Ratio3.75

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Sharda Cropchem Ltd

Competitors of Sharda Cropchem Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Epigral Ltd 7,680 Cr. 1,780 2,408/1,10721.5 4410.28 %25.2 %22.6 % 10.0
Dharmaj Crop Guard Ltd 804 Cr. 238 390/16523.1 1170.00 %12.0 %9.24 % 10.0
Bhaskar Agrochemicals Ltd 42.0 Cr. 80.6 122/46.110.8 34.10.00 %21.3 %24.7 % 10.0
Bhagiradha Chemicals & Industries Ltd 4,024 Cr. 310 448/185147 53.90.03 %7.44 %4.91 % 1.00
Best Agrolife Ltd 789 Cr. 334 732/24411.3 3200.90 %12.9 %9.95 % 10.0
Industry Average11,601.35 Cr1,591.9036.56435.980.33%15.27%19.95%7.25

All Competitor Stocks of Sharda Cropchem Ltd

Quarterly Result

MetricMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Sales 1,4348257221,0171,4826385816321,3127857779291,829
Expenses 1,1447726568101,1646975605631,0577086878151,525
Operating Profit 2905365207318-5921692557790115303
OPM % 20%6%9%20%21%-9%4%11%19%10%12%12%17%
Other Income 3201037262412-21925125
Interest 1101215101000
Depreciation 72556065687074695465696972
Profit before tax 2201815143255-105-3412198314646256
Tax % 20%-28%17%24%22%-15%-18%62%28%11%7%32%20%
Net Profit 1772312108199-89-285143274231204
EPS in Rs 19.622.511.3412.0122.04-9.82-3.060.5115.903.024.703.4522.56

Last Updated: May 31, 2025, 7:50 am

Below is a detailed analysis of the quarterly data for Sharda Cropchem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Sales, as of Mar 2025, the value is 1,829.00 Cr.. The value appears strong and on an upward trend. It has increased from 929.00 Cr. (Dec 2024) to 1,829.00 Cr., marking an increase of 900.00 Cr..
  • For Expenses, as of Mar 2025, the value is 1,525.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 815.00 Cr. (Dec 2024) to 1,525.00 Cr., marking an increase of 710.00 Cr..
  • For Operating Profit, as of Mar 2025, the value is 303.00 Cr.. The value appears strong and on an upward trend. It has increased from 115.00 Cr. (Dec 2024) to 303.00 Cr., marking an increase of 188.00 Cr..
  • For OPM %, as of Mar 2025, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Dec 2024) to 17.00%, marking an increase of 5.00%.
  • For Other Income, as of Mar 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Dec 2024) to 25.00 Cr., marking an increase of 24.00 Cr..
  • For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
  • For Depreciation, as of Mar 2025, the value is 72.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 69.00 Cr. (Dec 2024) to 72.00 Cr., marking an increase of 3.00 Cr..
  • For Profit before tax, as of Mar 2025, the value is 256.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Dec 2024) to 256.00 Cr., marking an increase of 210.00 Cr..
  • For Tax %, as of Mar 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 32.00% (Dec 2024) to 20.00%, marking a decrease of 12.00%.
  • For Net Profit, as of Mar 2025, the value is 204.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Dec 2024) to 204.00 Cr., marking an increase of 173.00 Cr..
  • For EPS in Rs, as of Mar 2025, the value is 22.56. The value appears strong and on an upward trend. It has increased from 3.45 (Dec 2024) to 22.56, marking an increase of 19.11.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:19 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Sales 7901,0611,2221,3991,7071,9982,0032,3963,5804,0453,1634,320
Expenses 6308789411,0751,3431,6211,6531,9452,8843,3862,8603,724
Operating Profit 160183281324364376350450696659303596
OPM % 20%17%23%23%21%19%17%19%19%16%10%14%
Other Income 322523149-22-124629406060
Interest 8989152016161520242
Depreciation 292335567099137170245248267275
Profit before tax 15517526127228723518530946443172378
Tax % 29%30%33%30%34%25%11%26%25%21%56%20%
Net Profit 11112317519019117616522934934232304
EPS in Rs 12.3113.6319.4121.1121.1419.5518.2525.4038.7137.903.5333.74
Dividend Payout % 16%18%21%19%19%20%22%20%16%16%85%27%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)10.81%42.28%8.57%0.53%-7.85%-6.25%38.79%52.40%-2.01%-90.64%850.00%
Change in YoY Net Profit Growth (%)0.00%31.47%-33.70%-8.05%-8.38%1.60%45.04%13.61%-54.41%-88.64%940.64%

Sharda Cropchem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:15%
5 Years:17%
3 Years:6%
TTM:37%
Compounded Profit Growth
10 Years:10%
5 Years:9%
3 Years:-4%
TTM:857%
Stock Price CAGR
10 Years:9%
5 Years:33%
3 Years:0%
1 Year:92%
Return on Equity
10 Years:15%
5 Years:12%
3 Years:10%
Last Year:13%

Last Updated: Unknown

Balance Sheet

Last Updated: January 13, 2025, 2:51 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 90909090909090909090909090
Reserves 3774665647158701,0451,1941,3131,5241,8222,1422,1472,204
Borrowings 4640382017000814731812
Other Liabilities 2843193545226869149149401,1631,7792,1081,7731,526
Total Liabilities 7969141,0471,3291,6462,2192,1982,3432,8583,7384,3434,0283,832
Fixed Assets 646488130210226372416544592668708983
CWIP 881331492102323602201611312122042830
Investments 97174959061222121168313432159336
Other Assets 5475427158991,1431,6111,3941,6502,0992,8003,4392,8782,513
Total Assets 7969141,0471,3291,6462,2192,1982,3432,8583,7384,3434,0283,832

Below is a detailed analysis of the balance sheet data for Sharda Cropchem Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is 90.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 90.00 Cr..
  • For Reserves, as of Sep 2024, the value is 2,204.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,147.00 Cr. (Mar 2024) to 2,204.00 Cr., marking an increase of 57.00 Cr..
  • For Borrowings, as of Sep 2024, the value is 12.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 18.00 Cr. (Mar 2024) to 12.00 Cr., marking a decrease of 6.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is 1,526.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,773.00 Cr. (Mar 2024) to 1,526.00 Cr., marking a decrease of 247.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is 3,832.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4,028.00 Cr. (Mar 2024) to 3,832.00 Cr., marking a decrease of 196.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is 983.00 Cr.. The value appears strong and on an upward trend. It has increased from 708.00 Cr. (Mar 2024) to 983.00 Cr., marking an increase of 275.00 Cr..
  • For CWIP, as of Sep 2024, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 283.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 283.00 Cr..
  • For Investments, as of Sep 2024, the value is 336.00 Cr.. The value appears strong and on an upward trend. It has increased from 159.00 Cr. (Mar 2024) to 336.00 Cr., marking an increase of 177.00 Cr..
  • For Other Assets, as of Sep 2024, the value is 2,513.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,878.00 Cr. (Mar 2024) to 2,513.00 Cr., marking a decrease of 365.00 Cr..
  • For Total Assets, as of Sep 2024, the value is 3,832.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,028.00 Cr. (Mar 2024) to 3,832.00 Cr., marking a decrease of 196.00 Cr..

Notably, the Reserves (2,204.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +1564619718117556146246267328341604
Cash from Investing Activity +-145-19-113-104-160-351-59-282-205-112-393-510
Cash from Financing Activity +-22-24-89-38132-215-6043-91-97-37-68
Net Cash Flow-113-640-11-11278-29120-8926

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow120.00145.00279.00324.00194.00376.00350.00369.00649.00656.00285.00596.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days178185156185175191148180177157165173
Inventory Days6257727411716996100117130145155
Days Payable130146117179186202167180180172176144
Cash Conversion Cycle111971118110615877100114115134184
Working Capital Days10185959699130711011059298129
ROCE %26%28%27%36%32%27%23%18%21%26%21%4%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters74.82%74.82%74.82%74.82%74.82%74.82%74.82%74.82%74.82%74.82%74.82%74.82%
FIIs1.69%2.16%2.37%2.41%2.14%2.00%2.01%2.06%2.14%2.02%2.52%3.77%
DIIs12.84%12.76%12.93%12.61%12.93%12.75%12.29%12.42%12.41%12.87%12.77%10.07%
Public10.64%10.26%9.88%10.15%10.09%10.44%10.87%10.70%10.63%10.29%9.91%11.33%
No. of Shareholders47,89861,04958,19261,10654,22252,12656,48356,85861,07554,43648,35358,717

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Small Cap Fund - Regular Plan 5,406,610 0.91 244.815,406,6102025-04-22 15:56:530%
DSP Small Cap Fund 3,587,791 1.2 162.463,587,7912025-04-22 15:56:530%
HDFC Hybrid Equity Fund - Regular Plan 1,977,870 0.4 89.561,977,8702025-04-22 05:57:460%
L&T Flexicap Fund - Regular Plan 356,312 0.46 13.34356,3122025-04-22 15:56:530%
DSP Equity Savings Fund 118,848 0.68 5.38118,8482025-04-22 17:25:210%
DSP Regular Savings Fund 24,639 0.63 1.1224,6392025-04-22 17:25:210%
Nippon India Nifty Smallcap 250 Index Fund 15,332 0.07 0.6915,3322025-04-22 17:25:210%
Motilal Oswal Nifty Smallcap 250 Index Fund 9,582 0.07 0.439,5822025-04-22 17:25:210%
SBI Nifty Smallcap 250 Index Fund 7,520 0.07 0.347,5202025-04-22 15:56:530%
ICICI Prudential Nifty Smallcap 250 Index Fund 3,579 0.07 0.163,5792025-04-22 15:56:530%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 3.5337.9038.7125.4018.25
Diluted EPS (Rs.) 3.5337.9038.7125.4018.25
Cash EPS (Rs.) 33.1565.4165.9144.3033.45
Book Value[Excl.RevalReserv]/Share (Rs.) 248.00247.44212.01178.96155.51
Book Value[Incl.RevalReserv]/Share (Rs.) 248.00247.44212.01178.96155.51
Revenue From Operations / Share (Rs.) 350.59448.36396.78265.53222.01
PBDIT / Share (Rs.) 37.9875.7478.8953.5035.90
PBIT / Share (Rs.) 8.3748.2451.7034.6120.70
PBT / Share (Rs.) 7.9747.7451.4634.3020.49
Net Profit / Share (Rs.) 3.5437.9138.7125.4118.25
NP After MI And SOA / Share (Rs.) 3.5337.9038.7125.4018.25
PBDIT Margin (%) 10.8316.8919.8820.1416.17
PBIT Margin (%) 2.3810.7513.0313.039.32
PBT Margin (%) 2.2710.6412.9612.919.22
Net Profit Margin (%) 1.008.459.759.568.22
NP After MI And SOA Margin (%) 1.008.459.759.568.22
Return on Networth / Equity (%) 1.4215.3218.2614.1911.73
Return on Capital Employeed (%) 3.0718.2822.7318.1012.53
Return On Assets (%) 0.787.859.338.007.01
Total Debt / Equity (X) 0.000.000.010.040.00
Asset Turnover Ratio (%) 0.750.850.930.800.73
Current Ratio (X) 1.861.651.691.841.96
Quick Ratio (X) 1.231.081.161.381.52
Inventory Turnover Ratio (X) 1.401.591.962.192.16
Dividend Payout Ratio (NP) (%) 85.7516.2115.497.8732.87
Dividend Payout Ratio (CP) (%) 9.149.399.104.5117.93
Earning Retention Ratio (%) 14.2583.7984.5192.1367.13
Cash Earning Retention Ratio (%) 90.8690.6190.9095.4982.07
Interest Coverage Ratio (X) 94.68151.52321.65174.12168.95
Interest Coverage Ratio (Post Tax) (X) 9.8276.83158.8483.6986.90
Enterprise Value (Cr.) 2811.464234.145420.452398.75816.79
EV / Net Operating Revenue (X) 0.881.051.511.000.40
EV / EBITDA (X) 8.216.207.624.972.52
MarketCap / Net Operating Revenue (X) 0.911.091.551.080.48
Retention Ratios (%) 14.2483.7884.5092.1267.12
Price / BV (X) 1.291.982.901.610.69
Price / Net Operating Revenue (X) 0.911.091.551.080.48
EarningsYield 0.010.070.060.080.16

After reviewing the key financial ratios for Sharda Cropchem Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 3.53. This value is below the healthy minimum of 5. It has decreased from 37.90 (Mar 23) to 3.53, marking a decrease of 34.37.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 3.53. This value is below the healthy minimum of 5. It has decreased from 37.90 (Mar 23) to 3.53, marking a decrease of 34.37.
  • For Cash EPS (Rs.), as of Mar 24, the value is 33.15. This value is within the healthy range. It has decreased from 65.41 (Mar 23) to 33.15, marking a decrease of 32.26.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 248.00. It has increased from 247.44 (Mar 23) to 248.00, marking an increase of 0.56.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 248.00. It has increased from 247.44 (Mar 23) to 248.00, marking an increase of 0.56.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 350.59. It has decreased from 448.36 (Mar 23) to 350.59, marking a decrease of 97.77.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 37.98. This value is within the healthy range. It has decreased from 75.74 (Mar 23) to 37.98, marking a decrease of 37.76.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 8.37. This value is within the healthy range. It has decreased from 48.24 (Mar 23) to 8.37, marking a decrease of 39.87.
  • For PBT / Share (Rs.), as of Mar 24, the value is 7.97. This value is within the healthy range. It has decreased from 47.74 (Mar 23) to 7.97, marking a decrease of 39.77.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 3.54. This value is within the healthy range. It has decreased from 37.91 (Mar 23) to 3.54, marking a decrease of 34.37.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 3.53. This value is within the healthy range. It has decreased from 37.90 (Mar 23) to 3.53, marking a decrease of 34.37.
  • For PBDIT Margin (%), as of Mar 24, the value is 10.83. This value is within the healthy range. It has decreased from 16.89 (Mar 23) to 10.83, marking a decrease of 6.06.
  • For PBIT Margin (%), as of Mar 24, the value is 2.38. This value is below the healthy minimum of 10. It has decreased from 10.75 (Mar 23) to 2.38, marking a decrease of 8.37.
  • For PBT Margin (%), as of Mar 24, the value is 2.27. This value is below the healthy minimum of 10. It has decreased from 10.64 (Mar 23) to 2.27, marking a decrease of 8.37.
  • For Net Profit Margin (%), as of Mar 24, the value is 1.00. This value is below the healthy minimum of 5. It has decreased from 8.45 (Mar 23) to 1.00, marking a decrease of 7.45.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.00. This value is below the healthy minimum of 8. It has decreased from 8.45 (Mar 23) to 1.00, marking a decrease of 7.45.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 1.42. This value is below the healthy minimum of 15. It has decreased from 15.32 (Mar 23) to 1.42, marking a decrease of 13.90.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 3.07. This value is below the healthy minimum of 10. It has decreased from 18.28 (Mar 23) to 3.07, marking a decrease of 15.21.
  • For Return On Assets (%), as of Mar 24, the value is 0.78. This value is below the healthy minimum of 5. It has decreased from 7.85 (Mar 23) to 0.78, marking a decrease of 7.07.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.00.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.75. It has decreased from 0.85 (Mar 23) to 0.75, marking a decrease of 0.10.
  • For Current Ratio (X), as of Mar 24, the value is 1.86. This value is within the healthy range. It has increased from 1.65 (Mar 23) to 1.86, marking an increase of 0.21.
  • For Quick Ratio (X), as of Mar 24, the value is 1.23. This value is within the healthy range. It has increased from 1.08 (Mar 23) to 1.23, marking an increase of 0.15.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.40. This value is below the healthy minimum of 4. It has decreased from 1.59 (Mar 23) to 1.40, marking a decrease of 0.19.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 85.75. This value exceeds the healthy maximum of 50. It has increased from 16.21 (Mar 23) to 85.75, marking an increase of 69.54.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 9.14. This value is below the healthy minimum of 20. It has decreased from 9.39 (Mar 23) to 9.14, marking a decrease of 0.25.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 14.25. This value is below the healthy minimum of 40. It has decreased from 83.79 (Mar 23) to 14.25, marking a decrease of 69.54.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 90.86. This value exceeds the healthy maximum of 70. It has increased from 90.61 (Mar 23) to 90.86, marking an increase of 0.25.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 94.68. This value is within the healthy range. It has decreased from 151.52 (Mar 23) to 94.68, marking a decrease of 56.84.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 9.82. This value is within the healthy range. It has decreased from 76.83 (Mar 23) to 9.82, marking a decrease of 67.01.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 2,811.46. It has decreased from 4,234.14 (Mar 23) to 2,811.46, marking a decrease of 1,422.68.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 1.05 (Mar 23) to 0.88, marking a decrease of 0.17.
  • For EV / EBITDA (X), as of Mar 24, the value is 8.21. This value is within the healthy range. It has increased from 6.20 (Mar 23) to 8.21, marking an increase of 2.01.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 23) to 0.91, marking a decrease of 0.18.
  • For Retention Ratios (%), as of Mar 24, the value is 14.24. This value is below the healthy minimum of 30. It has decreased from 83.78 (Mar 23) to 14.24, marking a decrease of 69.54.
  • For Price / BV (X), as of Mar 24, the value is 1.29. This value is within the healthy range. It has decreased from 1.98 (Mar 23) to 1.29, marking a decrease of 0.69.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 23) to 0.91, marking a decrease of 0.18.
  • For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.01, marking a decrease of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Sharda Cropchem Ltd as of June 1, 2025 is: 623.74

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 1, 2025, Sharda Cropchem Ltd is Overvalued by 15.48% compared to the current share price 738.00

Intrinsic Value of Sharda Cropchem Ltd as of June 1, 2025 is: 660.19

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 1, 2025, Sharda Cropchem Ltd is Overvalued by 10.54% compared to the current share price 738.00

Last 5 Year EPS CAGR: 5.84%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 24.08%, which is a positive sign.
  2. The company has higher reserves (1,260.23 cr) compared to borrowings (35.15 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (67.75 cr) and profit (268.67 cr) over the years.
  1. The stock has a high average Working Capital Days of 100.17, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 115.67, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sharda Cropchem Ltd:
    1. Net Profit Margin: 1%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 3.07% (Industry Average ROCE: 15.27%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 1.42% (Industry Average ROE: 19.95%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 9.82
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.23
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 21.9 (Industry average Stock P/E: 36.56)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Sharda Cropchem Ltd. is a Public Limited Listed company incorporated on 12/03/2004 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L51909MH2004PLC145007 and registration number is 145007. Currently Company is involved in the business activities of Wholesale of fertilizers and agrochemical products. Company's Total Operating Revenue is Rs. 3661.10 Cr. and Equity Capital is Rs. 90.22 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Agro Chemicals/PesticidesPrime Business Park, Dashrathlal Joshi Road, Mumbai Maharashtra 400056co.sec@shardaintl.com
http://www.shardacropchem.com
Management
NamePosition Held
Mr. Ramprakash V BubnaChairman & Managing Director
Mrs. Sharda R BubnaWhole Time Director
Mr. Ashish R BubnaWhole Time Director
Mr. Manish R BubnaWhole Time Director
Mr. M S Sundara RajanIndependent Director
Mr. Shitin DesaiIndependent Director
Mr. Shobhan ThakoreIndependent Director
Ms. Sonal DesaiIndependent Director
Mr. H S Upendra KamathAddnl. & Ind.Director
Mr. Vinod KathuriaAddnl. & Ind.Director
Mr. Shalin DivatiaAddnl. & Ind.Director

FAQ

What is the intrinsic value of Sharda Cropchem Ltd?

Sharda Cropchem Ltd's intrinsic value (as of 31 May 2025) is ₹623.74 — 15.48% lower the current market price of 738.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 6,657 Cr. market cap, FY2025-2026 high/low of ₹887/345, reserves of 2,204 Cr, and liabilities of 3,832 Cr.

What is the Market Cap of Sharda Cropchem Ltd?

The Market Cap of Sharda Cropchem Ltd is 6,657 Cr..

What is the current Stock Price of Sharda Cropchem Ltd as on 31 May 2025?

The current stock price of Sharda Cropchem Ltd as on 31 May 2025 is 738.

What is the High / Low of Sharda Cropchem Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Sharda Cropchem Ltd stocks is ₹887/345.

What is the Stock P/E of Sharda Cropchem Ltd?

The Stock P/E of Sharda Cropchem Ltd is 21.9.

What is the Book Value of Sharda Cropchem Ltd?

The Book Value of Sharda Cropchem Ltd is 277.

What is the Dividend Yield of Sharda Cropchem Ltd?

The Dividend Yield of Sharda Cropchem Ltd is 0.41 %.

What is the ROCE of Sharda Cropchem Ltd?

The ROCE of Sharda Cropchem Ltd is 16.0 %.

What is the ROE of Sharda Cropchem Ltd?

The ROE of Sharda Cropchem Ltd is 12.8 %.

What is the Face Value of Sharda Cropchem Ltd?

The Face Value of Sharda Cropchem Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Sharda Cropchem Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE